COVID-19 Antigen Test Market Report 2026

COVID-19 Antigen Test Market Overview

• COVID-19 Antigen Test market size has reached to $7.59 billion in 2025 • Expected to grow to $10.84 billion in 2030 at a compound annual growth rate (CAGR) of 7.4% • Growth Driver: Surge In Testing Fuels Growth Of The COVID-19 Antigen Test Market • Market Trend: Advancements In Rapid At-Home Multiplex Antigen Testing For Respiratory Infections • Asia-Pacific was the largest region in 2025.

What Is Covered Under COVID-19 Antigen Test Market?

COVID-19 is a contagious respiratory illness caused by Severe Acute Respiratory Syndrome COVID-19 2 (SARS-CoV-2) that infects the respiratory system of humans, causing infections ranging from the common cold to more severe respiratory diseases. The COVID-19 antigen test is a diagnostic test used to detect the presence of specific proteins from the SARS-CoV-2 virus, which causes COVID-19, in a person's respiratory specimen. The COVID-19 antigen test uses a sample typically collected from a nasal or throat swab. The main products and services of COVID-19 antigen tests are platforms, reagents and kits, and services. Platforms refer to a specific technology or system used for conducting specific tests. Nasopharyngeal swabs, oropharyngeal swabs, and nasal swab specimens are used by clinics and hospitals, home care, diagnostic labs, and other end-uses.

What Is The COVID-19 Antigen Test Market Growth Forecast?

The covid-19 antigen test market size is expected to see strong growth in the next few years. It will grow to $10.84 billion in 2030 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to preparedness for future outbreaks, expansion of decentralized testing, rising infectious disease surveillance, demand for affordable diagnostics, integration with digital health systems. Major trends in the forecast period include expansion of rapid point-of-care testing, growing adoption of home-based testing kits, increased demand for mass screening programs, simplification of sample collection methods, integration with public health surveillance.

Global COVID-19 Antigen Test Market Segmentation

1) By Product And Service: Platforms, Reagents And Kits, Services 2) By Specimen Type: Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab 3) By End-Use: Clinics And Hospitals, Home Care, Diagnostic Labs, Other End-Uses Subsegments: 1) By Platforms: Lateral Flow Platforms, ELISA Platforms 2) By Reagents And Kits: Test Kits, Reagents 3) By Services: Testing Services, Laboratory Services

What Is The Driver Of The COVID-19 Antigen Test Market?

An increase in testing rates is expected to propel the growth of the COVID-19 antigen test market going forward. Testing rates refer to how often diagnostic tests, such as COVID-19, are performed within a given population or over a specific period. As testing rates rise, there is an increased demand for COVID-19 testing solutions, including antigen tests. This surge in demand directly contributes to the market's growth, as manufacturers and suppliers need to produce and distribute more tests to meet the increased requirements. For instance, in October 2023, according to the National Institutes of Health (NIH), a US-based health organization, the total COVID-19 testing rate ranged from 5.13 to 22,386.63 per 1000 people from October 2022 to October 2023. Therefore, an increase in testing rates is driving the growth of the COVID-19 antigen test industry.

Key Players In The Global COVID-19 Antigen Test Market

Major companies operating in the covid-19 antigen test market are F. Hoffmann-La Roche AG, Abbott Laboratories, Becton And Dickinson and Company, Laboratory Corporation Of America, PerkinElmer Inc., Quidel Corporation, SD Biosensor Inc., Diasorin S.P.A, Biosynex Swiss SA, iHealth Labs Inc., Everlywell Inc., JOYSBIO Biotechnology Co. Ltd., Mylab Discovery Solutions Pvt. Ltd., Access Bio Inc., RayBiotech Life Inc., CTK Biotech Inc., Artron Laboratories Inc., Princeton BioMeditech Corporation, ACON Laboratories Inc., BioLytical Laboratories Inc., BioNote Inc., Assure Tech (Hangzhou) Co. Ltd., ADS biotech Inc., ANP Technologies Inc., BTNX Inc., Cellspect Co.Ltd., Empowered Diagnostics LLC, GenBody Inc., Beijing Wantai Biologicalpharmacy Enterprise Co. Ltd.

Global COVID-19 Antigen Test Market Trends and Insights

Major companies operating in the COVID 19 antigen test market are focusing on developing innovative solutions, such as rapid at home multiplex antigen tests, to meet the rising demand for fast, convenient, and accessible diagnosis of respiratory infections. Rapid at-home multiplex antigen tests are diagnostic kits that detect multiple pathogens, such as COVID-19 and influenza A and B, from a single sample, providing quick, accurate results at home to support timely isolation, treatment, and reduce the burden on healthcare facilities. For instance, in May 2024, iHealth Inc., a US-based digital health company, launched its 3 in 1 COVID 19/Flu A&B Rapid Test Kit, a user-friendly, over-the-counter (OTC) home antigen test that delivers results in just 15 minutes. The test uses an anterior nasal swab, with five drops of sample applied to a test card, and clearly displays differentiated results for COVID-19, influenza A, and influenza B using a color-coded readout. Unique features include its suitability for individuals aged 2 and above (with adult assistance for younger children), rapid turnaround, and the ease of self-collection without needing specialized skills or equipment. This innovation helps reduce pressure on healthcare facilities by enabling individuals to test themselves at home, get quick answers, and take appropriate steps, such as isolation or seeking care, much earlier.

What Are Latest Mergers And Acquisitions In The COVID-19 Antigen Test Market?

In June 2023, Avacta Group plc, a UK-based diagnostics and therapeutics company, acquired Coris Bioconcept SRL for an undisclosed amount. Through this acquisition, Avacta aims to expand its rapid diagnostics portfolio by integrating Coris Bioconcept’s range of professional-use lateral flow assays, including its COVID-19 antigen lateral flow test, and by leveraging Coris’s established manufacturing and distribution networks across Europe and international markets. Coris Bioconcept SRL is a Belgium-based diagnostic test manufacturer specializing in rapid lateral flow kits for respiratory, gastroenteric, and blood-borne pathogens.

Regional Outlook

Asia-Pacific was the largest region in the COVID-19 antigen test market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the COVID-19 Antigen Test Market?

The COVID-19 antigen test market consists of revenues earned by entities by providing services such as point-of-care testing (POC), telehealth services, travel testing services, and healthcare provider testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The COVID-19 antigen test market also includes sales of sample collection devices, extraction kits, buffers and solutions, and control materials. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the COVID-19 Antigen Test Market Report 2026?

The covid-19 antigen test market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the covid-19 antigen test industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.